Table 1 Effect of PALB2 Mutations on Bladder Cancer Risk
From: Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
Mutation subjects | Number of carriers/total (frequency %) | OR | 95% CI | p-value |
|---|---|---|---|---|
509_510delGA | ||||
Controls | 7/4702 (0.15) | 1.0 | ||
Cases | 4/1413 (0.3) | 1.9 | 0.55–6.51 | 0.5 |
172_175delTTGT | ||||
Controls | 3/4702 (0.06) | 1.0 | ||
Cases | 1/1413 (6.55) | 1.1 | 0.11–10.7 | 0.9 |
Any PALB2 mutation | ||||
Controls | 10/4702 (0.21) | 1.0 | ||
Cases | 5/1413 (0.35) | 1.7 | 0.56–4.88 | 0.52 |